BioStem Technologies Inc. Completes Two-Year Audit, Prepares for Uplisting to Senior Exchange
BIOSTEM TECHNOLOGIES NEW (BSEM)
NASDAQ:AMEX Investor Relations:
otcmarkets.com/stock/bsem/news/biostem-technologies-inc--announces-a-pre-clinical-study-of-bsem17-115-at-university-of-miami?id=177750&b=y
Company Research
Source: GlobeNewswire
POMPANO BEACH, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived biologics, today announced the successful completion of comprehensive audits for fiscal years 2022 and 2023. This completion is a significant step in the company’s strategy to uplist to a senior stock exchange. The primary purpose of this audit was to strategize BioStem's process and timing for transitioning to a fully reporting company with the Securities and Exchange Commission (SEC), focusing on its near-term fundraising plans. The successful audit is a strategic move toward uplisting to a senior exchange, which the company anticipates will help to further validate its market position, attract a broader investor base, and enhance shareholder value. Jason Matuszewski, CEO of BioStem Technologies, stated, "Completing this rigorous two-year audit underscores our
Show less
Read more
Impact Snapshot
Event Time:
BSEM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSEM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSEM alerts
High impacting BIOSTEM TECHNOLOGIES NEW news events
Weekly update
A roundup of the hottest topics
BSEM
News
- BioStem Technologies Granted Prioritized Examination for Wound Healing PatentGlobeNewswire
- BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain Allografts [Yahoo! Finance]Yahoo! Finance
- BioStem Technologies Retains Clinical Research Industry Veteran Nick McCoy to Lead DFU and VLU trials for BioREtain AllograftsGlobeNewswire
- BioStem Technologies to Present at the 2024 Planet MicroCap Showcase [Yahoo! Finance]Yahoo! Finance
- BioStem Technologies to Present at the 2024 Planet MicroCap ShowcaseGlobeNewswire